Day One Biopharmaceuticals: Of The Original Report To Include The Audited Consolidated Financial Statements Of Target (as Defined In The Original Report) As Of And For The Years Ended December 31, 2024 And December 31, 2023 And To Include The Unaudited Interim Condensed Consolidated Financial Statements Of Target As Of And For The Three And Nine Months Ended September 30, 2025; And (ii) Update The Information In Item 9.01(b) Of The Original Report To Include The Unaudited Pro Forma Condensed Combined Financial Information Of Parent And Target (collectively, The "

Show full article

This functionality is available for registred users only

• Full name
  Day One Biopharmaceuticals, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***